Synthego Stock
HealthTechLooking to sell Synthego stock or options?
Synthego has developed an advanced genome engineering platform that aims to streamline and enhance the drug discovery research process. Leveraging informatics and machine learning, their platform ensures precision and automation in genome engineering. This empowers genetic engineers and medical professionals to perform research that is both efficient and cost-effective.
Perceptive Advisors, Declaration Partners, Moore Strategic Ventures, Menlo Ventures, ZhenFund, AAF Management, Wellington Management, 8VC, Elements Capital Partners, GigaFund, AME Cloud Ventures, Tony Huang, SciFi VC, Moshen Chan, Chimera Capital, Intel Capital, Revelation Partners, Open Field Capital, Level One Fund, OS Fund, RA Capital Management, Founders Fund, Logos Capital, Alexandria Real Estate Equities, WI Harper Group.